0
CRISPR Therapeutics AG Banner Image

CRISPR Therapeutics AG has reached its limit for free report views

Work for CRISPR Therapeutics AG? Upgrade Your Profile and unlock all your annual reports.

CRISPR Therapeutics AG

  • Ticker CRSP
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
CRISPR Therapeutics AG Logo Image
  • 201-500 Employees
  • Based in Cambridge, Massachusetts
CRISPR Therapeutics is a leading gene editing company focused on developing transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 platform. CRISPR/Cas9 is a revolutionary gene editing technology that allows for precise, directed changes to genomic DNA. CRISPR Therapeutics has established a portfolio of therapeutic programs across a broad range of diseaseMore areas including hemoglobinopathies, oncology, regenerative medicine and rare diseases. To accelerate and expand its efforts, CRISPR Therapeutics has established strategic partnerships with leading companies including Bayer, Vertex Pharmaceuticals and ViaCyte, Inc. CRISPR Therapeutics AG is headquartered in Zug, Switzerland, with its wholly-owned U.S. subsidiary, CRISPR Therapeutics, Inc., and R&D operations based in Cambridge, Massachusetts, and business offices in San Francisco, California and London, United Kingdom.
CRISPR Therapeutics AG

Most Recent Annual Report

CRISPR Therapeutics AG MOST RECENT 2019 Annual Report and Form 10K

Report Locked. CRISPR Therapeutics AG has reached its limit for free report views.

Older/Archived Annual Reports